All posts by medical

Grey’s Anatomy cast: 19 famous guest stars and celebrity cameos from the last fifteen years – 9TheFIX

Grey's Anatomy has been on the air for 15 years, so it makes sense that a lot of big Hollywood names have popped up for guest slots over the last 16 seasons.

Established actors like Christina Ricci and Sarah Paulson have graced the halls of Seattle Grace hospital, as well as some young actors who went on to have big careers: Millie Bobby Brown and Abigail Breslin, to name a few.

Read more from the original source:
Grey's Anatomy cast: 19 famous guest stars and celebrity cameos from the last fifteen years - 9TheFIX

Study: The Link Between ApoE4 and Genetic Ancestries of Latinx Population – Being Patient

While researchers have known that the ApoE4 genetic variant is the strongest genetic risk factor for Alzheimers and related dementias, this finding is largely based on studies of people of European descent.

In a recent study published in the journal Alzheimers & Dementia, scientists found that the Amerindian (indigenous American) genetic ancestry is linked to a protective effect against the risk of ApoE4 on significant cognitive decline, furthering their understanding of how the genetic variant may have different effects among populations of Latino backgrounds.

Latinx populations suffer more from Alzheimers and dementia than other populations, Einat Granot-Hershkovitz, an author on the study and a research fellow in the Division of Sleep and Circadian Disorders at Brigham and Womens Hospital, said in a news release.

Historically, Latinx populations have been underrepresented in research, especially genetic research, she said. But our findings highlight how important it is to look beyond European ancestry and European genetic risk factors to understand in what ways genetics may or may not contribute to their risk.

Granot-Hershkovitz and colleagues examined data of 4,183 Latinx individuals from Cuban, Central American, Dominican, Mexican, Puerto Rican, and South American backgrounds with a mean age of 62.

The participants, who had European, African, and Amerindian genetic ancestries, received cognitive assessments after an average of seven years since their first assessment. Because many of them were too young to have developed Alzheimers and related dementias, the researchers examined related conditions such as significant cognitive decline and mild cognitive impairment, which can be precursors of dementia, while controlling for variables such as age and education.

The researchers found that ApoE4 was linked to the risk of cognitive decline in Latinx populations, especially for Cubans who had the lowest proportion of Amerindian ancestry compared to those with other backgrounds. They then found that a greater proportion of Amerindian genetic ancestry may protect againstthe risk of cognitive decline which accompanies ApoE4.

Lifestyle and environmental factors ranging from smoking and nutrition to sleep and air pollution may also play a role, the researchers noted, and future studies with older Latino populations that account for these factors is needed to tease out the associations.

Meanwhile, the study as well as past research focusing on Latino populations may help researchers better understand how APOE is linked to Alzheimers and related dementias in diverse populations, the scientists wrote, which can advance the development of personalized risk prediction and strategies to address Latinos health disparities in neurodegenerative aging and disorders.

Latinx populations should know that they are represented in this area of genetic research now, Granot-Hershkovitz said. Its not easy to participate in a research study, but there are revelatory findings from this amazing dataset, and hopefully there will be more in the future. This brings us a step further in addressing Latinx health disparities.

Contact Nicholas Chan at nicholas@beingpatient.com

See the article here:
Study: The Link Between ApoE4 and Genetic Ancestries of Latinx Population - Being Patient

Yale team finds way to protect genetic privacy in research – Yale News

(Illustration by Wendolyn Hill)

The era of functional genomics has enabled scientists to analyze massive amounts of data on cellular activity in disease and health. The more these data are shared between labs, the greater the power scientists have for finding genes linked to disease.

This widespread sharing of functional genomics data, however, creates a conundrum as it also makes the genetic privacy of individuals harder to protect.

In a new report, a team of Yale scientists has developed a way to protect peoples private genetic information while preserving the benefits of a free exchange of functional genomics data between researchers.

The report, published Nov. 12 in the journal Cell, was led by senior authorMark Gerstein, the Albert L Williams Professor of Biomedical Informatics and professor of molecular biophysics and biochemistry, of computer science, and of statistics and data science, and first authorGamze Gursoy, a postdoctoral researcher in Gersteins lab.

Genetic information is the most fundamental information of all, Gerstein said. If somebody gets access to your financial information, you can still get a new credit card. But once a genome is in a database, you are stuck and so are your children and grandchildren.

Genetic information is the most fundamental information of all. If somebody gets access to your financial information, you can still get a new credit card. But once a genome is in a database, you are stuck and so are your children and grandchildren.

Mark Gerstein

The widespread use of genetic testing by services such as Ancestry.com has already allowed individuals to identify relatives they had not known about. However, the huge genetic databases collected by scientists potentially can also be used for less benign uses.

For instance, a person with malicious intent and possession of DNA taken from a coffee cup could in theory identify a person who has HIV if that person had previously participated in a study about AIDs. In addition to the potential threat of blackmail, life insurance companies could refuse coverage for that individual. Similar risks exist for others who are, say, at high risk of developing cancer.

The privacy risk spans generations. Since individual genomic data are never erased, the grandson of a man with schizophrenia might one day face discrimination because of his inherited genetic predisposition for developing the disease.

There are societal risks as well. For instance, hostile foreign governments could hack databases looking for potentially damaging genetic information about U.S. citizens. Or authoritarian governments could use some data, as in so-called eugenics programs, to identify and harm individuals with undesirable traits.

Genetics has a problematic history, Gerstein says.

To overcome these privacy threats, Gursoy and Gerstein developed a method to quantify how much data from studies might be leaking or contain information that identifies individuals in the study. They then were able to sanitize or block access to small amounts of individually identifiable genetic information, while preserving the great majority of data for use by researchers.

We can protect individual privacy while still encouraging people to participate in genetic studies that are undeniably good for society, Gerstein said.

View post:
Yale team finds way to protect genetic privacy in research - Yale News

Save $50 and take a deep dive into your pups genetics with this dog DNA test – Yahoo News

The Daily Beast

A Delaware teenager has been charged with murder after allegedly luring her classmate into the woods and beating her to death alongside the girls ex-boyfriend, prosecutors said.Annika Stalczynski, 17, was arrested on Monday after a New Castle County grand jury indicted her on several chargesincluding first-degree murder, possession of a deadly weapon during commission of a felony, and conspiracyfor Madison Sparrows Oct. 2 slaying, according to the Delaware Attorney Generals office. Prosecutors allege Stalczynski, along with Sparrows ex-boyfriend, 19-year-old Noah Sharp, conspired to lure the teenager to the woods behind Maclary Elementary School, before they ambushed and fatally beat her with a metal baseball bat.The grand jury also indicted Sharp, who was arrested a few days after Sparrows death, on the same charges. The teenagers are in custody on $1 million bail.Utah Man Dies in Car Crash After Confessing He Killed His Wife: AuthoritiesEvery murder is an outrage, but the murder of a child strikes at everything we hold dear, Attorney General Kathy Jennings said in a statement. Madison was stolen from her family and friends with her life and her dreams still ahead of her. A life has been taken and a cruel trauma has been inflicted on hundreds of people who knew and loved this kind, gentle young woman.My heart aches for Madis parents, the Sparrow family, and the entire Newark Charter community. We can never replace what these people have lost, but we canand willhold her killers accountable, she added.According to court documents, prosecutors allege Sparrow, a junior at Newark Charter School, was reported missing by her mother at around 8:30 p.m. on Oct. 2 after she did not return from a trip to the store with a girlfriend.Another Fort Hood Soldier Has Been Arrested for Murder: AuthoritiesThe following day, police issued a Gold Alert for Sparrowa notification thats typically sent out when a senior citizen, suicidal person, or a person with a disability has gone missing. Investigators also spoke to friends and family, who revealed the 17-year-old had gone to an area in Newark where her ex-boyfriend Noah, was located.When authorities went to the wooded area, which was located behind Maclary Elementary School, they found an aluminum baseball bat, droplets of blood, and Sparrows clothing, according to court documents.Prosecutors state Sharp used the bat to fatally beat Sparrow to deathand that Stalczynski had planned the murder with the 19-year-old. An autopsy report confirmed Sparrow died of blunt force trauma to the head.It is not immediately clear why Stalczynski assisted Sharp in the grisly crime. But according to State Prosecutor A.J. Roop, Stalczynski and Sparrow were classmates at the Newark high school and had "known each other for some time."I believe that they had a relationship going back over a number of years, Roop said, according to Delaware Online. I won't get into much more than that, or what the status was recently, but they were acquaintances, and they did know each other.When investigators questioned Sharp on Oct. 5, following his arrest, the 19-year-old admitted he murdered his ex-girlfriendconfirming he used the bat to commit the crime, court documents state. Sharp added that after killing Sparrow, he moved her body to another wooded area about 20 minutes away from the elementary school off Route 896. Hours later, authorities found her body.Grand Jury Declines to Charge Officer Who Killed 21-Year-Old Dreasjon ReedSparrows death was met with an outcry of support online, where hundreds sent their condolences and shared stories about the 17-year-old and her family. Two vigils were also held in her honorone in New Jersey and one at her high schoolwhere hundreds of people met to honor the teenager described by her grandfather as wise beyond her years.To think such a bright light is extinguished at such a young age senselessly, Sparrow's grandfather, Tom Mason, said at one vigil last month. This was not an illness. This was not even a car accident. It was an act of violence. Its inconceivable.Although prosecutors do not state in court documents why Sharp wanted to kill his ex-girlfriend, they do reveal the 19-year-old admitted the crime was premeditated and that he and Stalczynski murdered Sparrow in the afternoon/evening hours the day the teenager went missing.On Tuesday, Jennings stressed his office cannot reveal any possible motives or additional details about the grisly crime because prosecutors are ethically restrained, for good reason.We want to make sure that fair trial rights are preserved, and quite frankly, we cannot imagine how painful this is for Madison's family and friends, Jennings said. We don't want them to suffer anymore.Read more at The Daily Beast.Got a tip? Send it to The Daily Beast hereGet our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.

Visit link:
Save $50 and take a deep dive into your pups genetics with this dog DNA test - Yahoo News

Direct-to-Consumer Genetic Testing: Global Markets and Technologies – GlobeNewswire

New York, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Direct-to-Consumer Genetic Testing: Global Markets and Technologies" - https://www.reportlinker.com/p05987656/?utm_source=GNW

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR) and genotyping microarrays.

The report then discusses several of the significant large-scale population sequencing initiatives that are contributing to DTC genetic testing development. Key forces driving the market are enumerated.

The structures of several important industry subsectors are reviewed, as well as major industry acquisitions and strategic alliances from January 2019 through September 2020. Industry subsectors analyzed include ancestry, clinical health, recreational health, sequencing data-based blockchain, sequencing instrument, long-read sequencing, sequencing informatics and PCR.

The market for DTC genetic testing is analyzed in depth. The market is analyzed by test purpose (ancestry, health, lifestyle); by technology platform (PCR, genotyping arrays, sequencing); by delivery format (test kits, virtual tests); and by geography (North America, Europe, Asia/Pacific, RoW).

The ancestry market segment is analyzed by technology and by ethnicity (African, Asian, European, Latino, other). The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and other). The lifestyle market segment is analyzed by technology and by application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness, other)

Market data covers 2019, 2020 (estimated) and 2025 (forecasted).

More than 55 companies in the DTC genetic testing industry are profiled in this report.

The analyst provides a summary of the main industry acquisitions and strategic alliances from January 2019 through September 2020, including key alliance trends.

Report Inludes: - 12 data tables and 39 additional tables - An overview of the global markets and technologies for direct to consumer (DTC) genetic testing - Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025 - Information on key genomic regions associated with genetic testing and description of instruments and technologies used for DTC genetic testing - Coverage of DNA sequencing; microarray; and software industries and description of the key initiatives in the genetic testing industry - Detailed analysis of the current market trends, market forecast and discussion of technological, regulatory and competitive elements as well as economic trends affecting the future marketplace for direct to consumer (DTC) genetic testing and impact analysis of COVID-19 on the market - Evaluation of key industry acquisitions and strategic alliances and market share analysis of the leading suppliers of the industry - Profiles of the key companies in the DTC testing industry, including Chendu 23Mofang Biotechnology Co. Ltd (23Mofand), Genetic Technologies Ltd, Illumina Inc., Myriad Genetics Inc., Thermo Fisher Scientific Inc., and Quest Diagnostics Inc.

Summary: Direct-to-consumer (DTC) genetic testing involves the analysis and interpretation of a persons genome. A consumer can access DTC genetic testing from a commercial company or from a health care provider.

DTC genetic testing has evolved in the past 10 years. Initially it focused on personal applications outside traditional health care, such as exploring ancestry and has trended toward interfacing with clinical care in non-traditional ways, such as partnerships between DTC companies with health systems.

Analysis of a customers genome helps to know about their ancestry inference, disease risks and other personal traits. Based on this, the main applications include ancestry, health and lifestyle.

Several factors are driving growth in the DTC genetic testing industry, including a shifting emphasis on health-related applications, the rise of personalized genomics and increasing convenience of ordering goods and services from virtual at-home settings. This latter trend has been accelerated by the COVID- 19 pandemic.

There is rising public awareness of DNA and its impact on health and genetic disorders, ancestry and lifestyle. These trends are having a favorable impact on the at-home genetic testing market. This report provides an in-depth analysis of the DTC genetic testing industryRead the full report: https://www.reportlinker.com/p05987656/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

View original post here:
Direct-to-Consumer Genetic Testing: Global Markets and Technologies - GlobeNewswire

Genetics Tied to Thromboembolism Risk With Inflammatory Bowel Disease – HealthDay News

WEDNESDAY, Nov. 18, 2020 (HealthDay News) -- Genetic variants in some patients with inflammatory bowel disease (IBD) are associated with a significantly increased risk for developing thromboembolic disease (TED), according to a study published online Oct. 21 in Gastroenterology.

Takeo Naito, Ph.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues used whole-exome sequencing and genome-wide genotyping to determine the proportion of 792 IBD patients genetically at risk for TED and investigate the effect of the genetic risk for TED in IBD.

The researchers found that 122 of 792 IBD patients (15.4 percent) were genetically at high risk for TED. Among the 715 patients with documented TED status, 8.8 percent had TED events. There was a significant association between genetic TED risk and increased TED events (odds ratio, 2.5). The investigators also observed an additive effect of monogenic and polygenic risk on TED. There was more frequent thrombosis at multiple sites seen among patients with high TED genetic risk (78 versus 42 percent; odds ratio, 3.96).

"Our results suggest that genetic traits identify approximately one in seven IBD patients who will experience 2.5-fold or greater risk for TED," the authors write.

Several authors disclosed financial ties to the pharmaceutical and biotechnology industries.

Abstract/Full Text (subscription or payment may be required)

Here is the original post:
Genetics Tied to Thromboembolism Risk With Inflammatory Bowel Disease - HealthDay News

LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers -…

LOS ANGELES, Nov. 18, 2020 /PRNewswire/ -- Today, the Los Angeles Network for Enhanced Services (LANES) and TheLos AngelesCountyDepartmentof Health Services (DHS) announced their co-partnership with Fulgent Genetics Inc. (NASDAQ:FLGT) to support the data exchange of coronavirus tests performed at nearly 20 local drive-thru, walk-up and community clinic testing sites. As COVID-19 infections hit record levels in LA County, access to the most relevant test data is essential for healthcare providers to inform patient care decisions.

"We're committed to broad-scale Los Angeles County public health response to help our medical community participants significantly curtail the outbreak," said Ali Modaressi, CEO of LANES. "Our collaboration with Fulgent Genetics and DHS will fast-track getting COVID-19 test results in the hands of our dedicated Los Angeles providers who use our health information exchange platform. Physicians and other clinicians can view their patient's test results along with other pertinent clinical information in real time to make the best treatment decision for the patient."

Since May 25, Fulgent Genetics has administered thousands of laboratory-developed tests daily at community sites across Southern California to support the state's public health pandemic crisis. The partnership facilitates the electronic sharing of COVID-19 test results with DHS and LANES. LANES serves as the community's connectivity conduit posting COVID-19 test results to the patient's electronic health record (EHR) within 24 hours turnaround of the resident being tested.

According to James Xie, Chief Operating Officer, Fulgent Genetics, "Fulgent Genetics is committed to delivering up-to-the-minute COVID-19 test results through our COVID testing technology platform. The fast availability of our trustworthy results data shared through DHS and LANES is valuable for LA County officials and healthcare providers alike to aid in the public health detection, tracking, prevention, and management of the disease."

Many of the freestanding walk-thru and drive-thru testing sites are set up by DHS and other county public health agencies. In some cases, testing sites are unable to transfer the data to some community clinics lacking EHR connectivity capabilities.

LANES is the first HIE in the greater Los Angeles area to take action making COVID-19 testing results easily accessible to doctors, nurses and clinicians delivering care on the front lines. Additional value is offered in the platform's notifications at the population level that empower providers to be proactive when they see five out of 20 patients tested positive, for example.

"One of the faster online ways to disseminate test results to community providers, particularly for county clinics and hospital systems, is through an established health information exchange," said Clemens Hong, M.D., lead of COVID-19 testing at DHS.

"When a patient seeks care at a community hospital or clinic, it's really important for a provider to have that prior COVID-19 test result," continued Dr. Hong. "And since LANES assures proper patient identification matching, providers avoid duplicate testing while ensuring the most timely and informed care possible for the individual based on the results at hand."

For more information including locations about COVID-19 testing sites offered through the County of Los Angeles, visit https://covid19.lacounty.gov/testing/.

About LANES Los Angeles Network for Enhanced Services (LANES) is a community-based health information exchange (HIE) serving more than 500 health systems, hospitals and clinics that administer care to residents of Los Angeles County. Medi-Cal providers can tap Cal-HOP funds to access LANES. Connect with us onTwitterandLinkedInor visit theLANES websitefor more information.

About TheLos AngelesCountyDepartmentof Health Services (DHS) The Los Angeles County Department of Health Services (DHS) is the second largest municipal health system in the nation. Through its integrated system of 27 health centers and four hospitals - and expanded network of community partner clinics DHS annually provides direct care for 600,000 unique patients, employs over 23,000 staff, and has an annual budget of over $6.2 billion. For additional information regarding DHS please visitwww.dhs.lacounty.gov.

AboutFulgent Genetics, Inc. Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Combining next generation sequencing ("NGS") with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs.

Media Contact: Angela Jenkins Angela Jenkins & Associates for LANES 303.877.0115 [emailprotected]

Media Contact: Los Angeles County Joint Information Center - COVID-19 424.241.3775 [emailprotected]

Media Contact: Jeff Fox The Blueshirt Group [emailprotected]

SOURCE Los Angeles Network for Enhanced Services

Home (New)

See the original post here:
LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers -...

Ancient Dog DNA Reveals Their Enduring Connection With People – WIRED

After that domestication event, some things do seem to have stayed constant. According to the teams results, after dogs split off from wolves over 11,000 years ago, wolves never made a major reentry into dog populations (until, perhaps, the contemporary craze for wolfdogs). Given that dogs and wolves belong to the same species and produce perfectly healthy offspring, this discovery came as a surprise to the authors. They inferred this result from the observation that some wolves are equally related to all ancient and modern dogs, which indicates that all dogs have the same amount of wolf ancestry. The logical explanation is that wolves didnt contribute substantially to the dog gene pool after domestication. If, instead, wolves had continued interbreeding with dogs, the team would have expected to observe that all wolves were more closely related to some dogswhich had wolves in their family trees post-domesticationthan others, which only had dog ancestors.

But, for some reason, the opposite happened when it comes to the wolf genome: Dogs are universally more related to some wolves than they are to others, which indicates that dogs did in fact contribute genetic material to wolf populations. This asymmetry between dogs and wolves may have a simple explanation: humans. It shows us, Lindblad-Toh says, that probably people held onto their dogs and took good care of them and made sure that they didn't let wolves in. The wolves had no such guardians.

But Liisa Loog, a postdoctoral researcher in the Genetics Department at the University of Cambridge who was not involved in the study, believes that it is important to keep this result in perspective. She notes that the authors argument depends on some specific assumptions about how ancient wolves relate to modern wolves, assumptions that are impossible to confirm without studying ancient wolves directly. The authors here rely on the assumption that this happened on a now-extinct wolf population that hasnt been sampled, and that is equally related to all modern-day wolf populations, she says. This may be the case, but it also may not be the case.

This assumption, and the assumptions about geographic and climatic consistency that undergird Bergstrm and Frantzs trade hypothesis, do mean that their results and theories cant be confirmed without additional research, like similar studies of ancient wolf DNA. But, ultimately, 27 dog genomes are a narrow window onto the past: When working with such a small amount of data, assumptions become necessary. The DNA itself is just DNA, Bergstrm says. It needs that wider context of interpretation.

The scarcity of evidence, coupled with the difficulty of extracting high-quality DNA from such old bones, might make ancient DNA research seem like a foolhardy endeavorwhy not just obtain genetic samples from modern dogs and figure out the family tree from there? But ancient DNA also has some distinct advantages over modern DNA, especially when it comes to dogs. Many contemporary dogs owe their genetic profiles to the Victorian dog breeding craze, so the signatures of their more distant past may be difficult to discern. Looking for evidence about ancient dogs in the genomes of modern ones is like searching for a needle in a haystack, Loog says. So it can help to go directly to the source. Ancient DNA, Loog says, literally gives us this time-stamped genetic picture of the past.

So, while it may be difficult to learn about prehistoric dogs by studying their modern descendants, the special insights afforded by ancient DNA can provide invaluable context for understanding how humans relate to dogs today. Dogs are kind of unique in that they are a predator, a carnivore. And they were domesticated by hunter-gatherers, way before agriculture, and they were also able to spread so quickly to most groups, Bergstrm says. Its somehow a surprisingly good fit for the human species to take on this animal as a companioneven though, a priori, it seems like an unlikely candidate for domestication. If Bergstrm and his colleagues are right, the human tradition of living with, breeding, and protecting dogs, and of treating canines not just as useful tools but as sources of social connection and emotional support, could have an 11,000-year history. Even before they figured out how to cultivate crops, humans may very well have known how to take care of, and be taken care of by, their animals.

More Great WIRED Stories

See the article here:
Ancient Dog DNA Reveals Their Enduring Connection With People - WIRED

Endometriosis and depression: is there a genetic link? – ABC News

Norman Swan: For something that affects one in three women and costs sufferers about $30,000 a year in lost work and healthcare costs, we don't know enough about endometriosis. That's when the tissue similar to the lining of the uterus grows elsewhere in the body and can cause pain, especially pain in the pelvis, and even infertility. And so awareness of endometriosis is much better than it used to be but it was often dismissed as a women's issue. But a new genetic study is showing endometriosis has a genetic link to depression and gut issues and there might be a cause-and-effect link. Hi Tegan, you've been looking at this.

Tegan Taylor: Hi, yes, it's a crazy link to be showing, isn't it. It's the sort of thing where you go maybe if you had debilitating pain every month and your doctors couldn't give you an answer, it wouldn't be surprising if you are depressed. But actually looks like the genetic cause and effect link actually works in the other direction.

Norman Swan: So tell me about the study.

Tegan Taylor: So this is a really big study that looked at a couple of big genetic databases, and basically they were looking for a shared genetic risk factor for depression and endometriosis because they knew that observational studies have shown that in women with depression, they are twice as likely as the general population to have endometriosis, and similarly in women with endometriosis they are twice as likely as the general population to have depression. So there seemed to be a link there.

And so they were looking for a shared genetic risk factor, and they found several actually. And then when they did more analysis, they showed this cause-and-effect relationship between depression on endometriosis, and they both seemed to have a causal relationship with something that is involving the gastric mucosa, so gastrointestinal reflux disease or gastritis peptic ulcers. And so there does seem to be some kind of linear relationship between the genes that are maybe malfunctioning to cause these gastric conditions and things like depression and endometriosis.

Norman Swan: These studies are called Genome Wide Association Studies, so they are not gene sequencing, they are looking at 700,000 separate points in the genome, and these points called SNPs are near where genes might be, and they have been criticised as exercises in just gathering data which might not be important or they might just be accidental associations.

Tegan Taylor: Yes, it fits into a broader field of research where we've got these observational studies on one side where it looks like people are more likely to have one of these things if they've got the other thing, but you can't show the cause-and-effect. And so I spoke to one of the researchers from the study, Dale Nyholt from the Queensland University of Technology, and he said that when you look at the genetics, you're able to draw a clean link between endo and these other conditions.

Dale Nyholt: As a geneticist, we always look at genetics because it's less influenced by some of these other environmental factors that could make something look like it's comorbid, but if we find shared genetic risk factors, well that's in your germline, so that's what you've inherited. And by doing these type of analyses that we've done, we really confirm and validate that there's something that's biologically shared across individuals that suffer these traits.

Norman Swan: That's Dale Nyholt from the Queensland University of Technology. So what does this mean for women living with endometriosis, Tegan?

Tegan Taylor: Well, when I started reporting on this study I thought I'd put the call out to my friends and family, see if there's anyone who I knew who had this experience. I was staggered by the number of people who replied, and the stories are just heartbreaking. And that idea of what Dale just said about validating, he was talking about validating in a scientific sense, but I think for women personally it is very validating to hear that this is a genetic thing.

Delayed diagnosis is really common with endometriosis. People don't feel seen or understood or, like you said at the beginning, they are dismissed as having women's troubles. But in addition to that, this lack of continuity of care and this frustration of being sent back and forth between doctors. So, one woman was being treated for endometriosis and was told that she had irritable bowel syndrome, but when she saw a gut doctor they were, like, no, you've got endometriosis, and she is just being flicked back and forth between specialists. So this appreciation that these cases might be interlinked is really valuable.

And so one of the people I spoke to was Sophie Volker, and she's got a history of depression as well as endometriosis and gut problems, but like many women it took her a really long time to get a diagnosis, and her doctors didn't immediately draw the link between the three conditions.

Sophie Volker: I had had really painful periods, had had gut problems forever, just thought that was a pretty normal part of my life. And so I think the confusion of not having any kind of answers, not having a diagnosis and having pain all the time probably did contribute a little bit to my being depressed.

Norman Swan: That's Sophie Volker. I mean, it's fine to say there's a genetic link, and the researchers think it is cause and effect, but if it is cause and effect, what's the biological mechanism?

Tegan Taylor: They think it has something to do with inflammation, so these genetic pathways, it's not like the only job that they have is to give someone endo or to give someone depression, they're gene sequences that have to do with cell death and repair, and they do all sorts of different things, but they think that inflammation is playing a role.

And so one of theI mean, yes, you sort of do this genetic analysis and then it's up to some other group of researchers to figure out what to do with, but there have been some other studies already into whether diet interventions, for example a low FODMAP diet can be helpful in people with endometriosis, and they've had promising results. So this helps put that into context and it would be good to see more research in that space.

And it also has implications for the sorts of medications that people are prescribed. So if you've got a gut problem, then taking a nonsteroidal anti-inflammatory for your endometriosis pain might not be appropriate because you've got gut problems. But also because we do know what genetic pathways might be involved now, then those pathways and genes could be potential targets for drugs, especially in those people who have both endometriosis and depression.

Norman Swan: And I suppose the other thing is that there is evidence from some interesting antidepressants, tricyclics, that they can have odd effects that have got nothing to do with actually their antidepressant effects, and it could be that you start to use antidepressants not for necessarily their effect on depression but they could have an effect on the endometriosis.

Tegan Taylor: Perhaps, exactly, and it also highlights the importance for screening. So if you've got someone coming in with, say, depression and gut problems and they are a woman, screening them for endometriosis as well because there is a higher than average likelihood that that woman also has endometriosis.

Norman Swan: Have we given GPs a lot of work after today's Health Report! You've got to work out the fish oil tablets, and you got to work out the depression and they've got problems in endometriosis, all serious issues.

See more here:
Endometriosis and depression: is there a genetic link? - ABC News

Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne, Pioneer of Biomolecular Condensates Field – Newswise

Newswise BOSTON, Nov. 16, 2020 /PRNewswire/ --Apple Tree Partners (ATP), a leading life sciences venture firm, today announced the launch of Nereid Therapeutics, a company dedicated to discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates. ATP created Nereid with Clifford P. Brangwynne, Ph.D., professor in the Department of Chemical and Biological Engineering at Princeton University and an investigator at the Howard Hughes Medical Institute. Nereid commences operations with a $50 million Series A funding commitment from ATP.

Brangwynne, a biophysicist, is a pioneer of the field of biomolecular condensateswork for which he has won numerous awards, including a 2018 MacArthur Foundation "Genius" grant. He has discovered and elucidated the biophysical principles underlying how liquid-liquid phase separation drives the organization, material properties, function, and dysfunction of these ubiquitous structures in living cells. The Nereid drug discovery platform builds from a set of proprietary technologies, developed in the Brangwynne Lab at Princeton, that utilize advanced microscopy and computer vision to enable the precise measurement, interrogation, and control of phase separation in living mammalian cells. The platform holds promise to enable completely new approaches to discovering and developing therapeutics across a range of diseases; Nereid's near-term efforts will focus on certain cancers and neurodegenerative disorders in which pathological protein behaviors are governed or influenced by phase transitions.

"We are excited to partner with Cliff, an originator of and luminary in the fast-expanding field of condensate biophysics, to translate the vast potential of this science into new medical treatments to improve patients' lives," said Spiros Liras, Ph.D., a venture partner at ATP who will be Nereid's interim CEO. "Nereid possesses a unique suite of technologies with unmatched capabilities in phase separation, droplet visualization, and machine-learning-enabled quantitative mapping and measurementand together these tools comprise a system well-suited to rapidly identify and study novel therapeutic interventions."

The Nereid Board of Directors chaired by Seth Harrison, M.D., ATP's founder and managing partner, includes ATP venture partner and Chief Scientific Officer Michael Ehlers, M.D., Ph.D.; Liras; and Robert J. Hugin, former Chairman and Chief Executive Officer of Celgene Corporation. Brangwynne will maintain a Board observer seat and will chair Nereid's Scientific Advisory Board.

Clifford Brangwynne received a B.S. (2001) in Materials Science and Engineering from Carnegie Mellon University and a Ph.D. (2007) in Applied Physics from Harvard University. He was a postdoctoral researcher at the Max Planck Institute of Molecular Cell Biology and Genetics and the Max Planck Institute for the Physics of Complex Systems from 2007 to 2010, prior to joining the faculty of Princeton University in 2011, where he is currently a professor in the Department of Chemical and Biological Engineering, and an investigator at the Howard Hughes Medical Institute. His pioneering work on biomolecular condensates has been recognized with numerous awards, including a Macarthur Fellowship (2018), Wiley Prize (2020), Blavatnik Award (2020), and the HFSP Nakasone Award (2021).

About ATP

Founded in 1999, ATP is a leader in life sciences venture capital. ATP creates companies starting with assets at various stages, from working with scientists on pre-IP ideas, to spinning out assets from existing companies. We provide flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises that create therapies for unmet medical needs.We invest in our companies from seed stage through IPO and beyond, enabling their success with our world-class team of venture partners and EIRs. For more information, visitwww.appletreepartners.com.

About Nereid Therapeutics

Nereid Therapeutics, an ATP company, is discovering new disease treatments using proprietary state-of-the-art technologies for generating, visualizing, and measuring liquid-liquid phase separation and the resulting biomolecular condensates. Nereid applies leading expertise in soft matter physics and cell biology to pioneer completely new ways to fight intractable diseases. For more information, visitwww.nereidtx.com.

Follow this link:
Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne, Pioneer of Biomolecular Condensates Field - Newswise